WINT•benzinga•
Windtree Therapeutics Announces That An Istaroxime Presentation Featuring The Phase 2B Seismic Study Was Given On February 11, 2025 At The Technology And Heart Failure Therapeutics Conference In Boston, Massachusetts
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on February 12, 2025 by benzinga